Innovative Eyewear, Inc.

LUCY Healthcare Medical Instruments & Supplies

Innovative Eyewear, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.7 million, up 62.7% from fiscal 2024. In the quarter to June 2026, revenue grew 74.5%, EPS grew 60.6%, free cash flow grew 9.61% and total debt fell 92.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

0.79 0.05 −5.95%
Market cap
$7.3M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
−3.75
Beneish M
−2.44
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
1.46 2.28 1.50 3.93
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(2.68) (2.73) (2.96) (6.28)
P/B ratio
0.72 0.81 0.44 0.92
EV/Sales
0.39 0.41 (0.91) 0.63
EV/EBITDA
0.00 0.00 0.29 0.00
EV/FCF
(0.17) (0.16) 0.32 (0.18)
Current Ratio
12.06 8.02 9.03 11.98
Net Debt/EBITDA
2.23 2.41 2.63 4.21
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
(165.38%) (155.05%) (204.00%) (112.44%)
Free Cash Flow Yield
(151.29%) (114.29%) (189.86%) (87.34%)
Free Cash Flow per Share
(0.30) (0.41) (0.39) (0.31)
Book value per Share
1.08 1.34 2.27 2.10
Free Cash Flow
(1.91) (2.55) (1.54) (1.51)
EV/EBIT
0.00 0.00 0.29 0.00
Other line items

Show all line items

Columns are period end dates